Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
Plos One|October 23, 2013
207-nm UV light - a promising tool for safe low-cost reduction of surgical site infections. I: in vitro studiesManuela Buonanno, Gerhard Randers-Pehrson, Alan W Bigelow, et al.Clinical Trials (London, England)|April 9, 2015
Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trialLiza Dawson, Sam Garner, Chuka Anude, et al.AIDS Research and Human Retroviruses|November 6, 2009
Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in ThailandHong Van Tieu, Jintanat Ananworanich, Anchalee Avihingsanon, et al.Antiviral Therapy|September 13, 2006
Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118)Barbara M Gripshover, Heather Ribaudo, Jorge Santana, et al.AIDS Patient Care and Stds|May 21, 2014
Patterns of geographic mobility predict barriers to engagement in HIV care and antiretroviral treatment adherenceBarbara S Taylor, Emily Reyes, Elizabeth A Levine, et al.Statistical Communications in Infectious Diseases|November 28, 2012
A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine RegimensPeter B Gilbert, Douglas Grove, Erin Gabriel, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2016
Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current EvidenceBrett Hanscom, Holly E Janes, Peter D Guarino, et al.The Journal of Infectious Diseases|January 28, 2010
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patientsElias K Halvas, Ann Wiegand, Valerie F Boltz, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudinePaul M Coplan, John R Cook, George W Carides, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2009
Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapyAshraf Coovadia, Gillian Hunt, Elaine J Abrams, et al.Pageof 8